Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.

Magistrado PA, Corey VC, Lukens AK, LaMonte G, Sasaki E, Meister S, Wree M, Winzeler E, Wirth DF.

ACS Infect Dis. 2016 Nov 11;2(11):816-826.

2.

Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites.

Chebon LJ, Ngalah BS, Ingasia LA, Juma DW, Muiruri P, Cheruiyot J, Opot B, Mbuba E, Imbuga M, Akala HM, Bulimo W, Andagalu B, Kamau E.

PLoS One. 2016 Sep 9;11(9):e0162524. doi: 10.1371/journal.pone.0162524.

3.

Therapeutic efficacy and effects of artesunate-amodiaquine and artemether-lumefantrine on malaria-associated anaemia in Nigerian children aged two years and under.

Sowunmi A, Akano K, Ayede AI, Ntadom G, Adewoye EO, Fatunmbi B, Aderoyeje T.

Infect Dis Poverty. 2016 Jul 6;5(1):70. doi: 10.1186/s40249-016-0165-2.

4.

Comparison of allele frequencies of Plasmodium falciparum merozoite antigens in malaria infections sampled in different years in a Kenyan population.

Ochola-Oyier LI, Okombo J, Wagatua N, Ochieng J, Tetteh KK, Fegan G, Bejon P, Marsh K.

Malar J. 2016 May 6;15(1):261. doi: 10.1186/s12936-016-1304-8.

5.

PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers.

Eastman RT, Khine P, Huang R, Thomas CJ, Su XZ.

Sci Rep. 2016 May 5;6:25379. doi: 10.1038/srep25379.

6.

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.

Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Zampa O, Valéa I, Sorgho H, Owusu-Dabo E, Ouédraogo JB, Guiguemdé TR, Tinto H.

PLoS One. 2016 Mar 31;11(3):e0151565. doi: 10.1371/journal.pone.0151565.

7.

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.

Ménard S, Ben Haddou T, Ramadani AP, Ariey F, Iriart X, Beghain J, Bouchier C, Witkowski B, Berry A, Mercereau-Puijalon O, Benoit-Vical F.

Emerg Infect Dis. 2015 Oct;21(10):1733-41. doi: 10.3201/eid2110.150682.

8.

Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.

WWARN Parasite Clearance Study Group., Abdulla S, Ashley EA, Bassat Q, Bethell D, Björkman A, Borrmann S, D'Alessandro U, Dahal P, Day NP, Diakite M, Djimde AA, Dondorp AM, Duong S, Edstein MD, Fairhurst RM, Faiz MA, Falade C, Flegg JA, Fogg C, Gonzalez R, Greenwood B, Guérin PJ, Guthmann JP, Hamed K, Hien TT, Htut Y, Juma E, Lim P, Mårtensson A, Mayxay M, Mokuolu OA, Moreira C, Newton P, Noedl H, Nosten F, Ogutu BR, Onyamboko MA, Owusu-Agyei S, Phyo AP, Premji Z, Price RN, Pukrittayakamee S, Ramharter M, Sagara I, Se Y, Suon S, Stepniewska K, Ward SA, White NJ, Winstanley PA.

Malar J. 2015 Sep 22;14:359. doi: 10.1186/s12936-015-0874-1.

9.
10.

Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data.

WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group., Dahal P, d'Alessandro U, Dorsey G, Guerin PJ, Nsanzabana C, Price RN, Sibley CH, Stepniewska K, Talisuna AO.

BMC Med. 2015 Sep 7;13:212. doi: 10.1186/s12916-015-0445-x. Review.

11.

Effectiveness and safety of artemether-lumefantrine versus artesunate-amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial.

Sondo P, Derra K, Diallo-Nakanabo S, Tarnagda Z, Zampa O, Kazienga A, Valea I, Sorgho H, Owusu-Dabo E, Ouedraogo JB, Guiguemde TR, Tinto H.

Malar J. 2015 Aug 20;14:325. doi: 10.1186/s12936-015-0843-8.

12.

Antimalarial drug resistance in Africa: key lessons for the future.

Takala-Harrison S, Laufer MK.

Ann N Y Acad Sci. 2015 Apr;1342:62-7. doi: 10.1111/nyas.12766. Review.

13.

Occurrence of pfatpase6 Single Nucleotide Polymorphisms Associated with Artemisinin Resistance among Field Isolates of Plasmodium falciparum in North-Eastern Tanzania.

Chilongola J, Ndaro A, Tarimo H, Shedrack T, Barthazary S, Kaaya R, Masokoto A, Kajeguka D, Kavishe RA, Lusingu J.

Malar Res Treat. 2015;2015:279028. doi: 10.1155/2015/279028.

14.

Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.

Ndour PA, Lopera-Mesa TM, Diakité SA, Chiang S, Mouri O, Roussel C, Jauréguiberry S, Biligui S, Kendjo E, Claessens A, Ciceron L, Mazier D, Thellier M, Diakité M, Fairhurst RM, Buffet PA.

J Infect Dis. 2015 Jan 15;211(2):290-7. doi: 10.1093/infdis/jiu427.

15.

Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.

Henriques G, Hallett RL, Beshir KB, Gadalla NB, Johnson RE, Burrow R, van Schalkwyk DA, Sawa P, Omar SA, Clark TG, Bousema T, Sutherland CJ.

J Infect Dis. 2014 Dec 15;210(12):2001-8. doi: 10.1093/infdis/jiu358.

16.

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.

Tinto H, Bonkian LN, Nana LA, Yerbanga I, Lingani M, Kazienga A, Valéa I, Sorgho H, Kpoda H, Guiguemdé TR, Ouédraogo JB, Mens PF, Schallig H, D'Alessandro U.

Malar J. 2014 May 31;13:207. doi: 10.1186/1475-2875-13-207.

17.

Detection of persistent Plasmodium spp. infections in Ugandan children after artemether-lumefantrine treatment.

Betson M, Sousa-Figueiredo JC, Atuhaire A, Arinaitwe M, Adriko M, Mwesigwa G, Nabonge J, Kabatereine NB, Sutherland CJ, Stothard JR.

Parasitology. 2014 Dec;141(14):1880-90. doi: 10.1017/S003118201400033X.

18.

A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.

Wendler JP, Okombo J, Amato R, Miotto O, Kiara SM, Mwai L, Pole L, O'Brien J, Manske M, Alcock D, Drury E, Sanders M, Oyola SO, Malangone C, Jyothi D, Miles A, Rockett KA, MacInnis BL, Marsh K, Bejon P, Nzila A, Kwiatkowski DP.

PLoS One. 2014 May 8;9(5):e96486. doi: 10.1371/journal.pone.0096486.

19.

Impact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.

Halliday KE, Okello G, Turner EL, Njagi K, Mcharo C, Kengo J, Allen E, Dubeck MM, Jukes MC, Brooker SJ.

PLoS Med. 2014 Jan 28;11(1):e1001594. doi: 10.1371/journal.pmed.1001594.

20.

Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria.

Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, Arinaitwe E, Tappero JW, Kaharuza F, Kamya MR, Dorsey G.

Malar J. 2014 Jan 28;13:32. doi: 10.1186/1475-2875-13-32.

Items per page

Supplemental Content

Support Center